Therapies for Treatment-Resistant Panic Disorder Symptoms

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will determine the effectiveness of different treatments for panic disorder symptoms in individuals who still have symptoms after initial treatment with medication.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Massachusetts General Hospital
• Collaborator: National Institute of Mental Health (NIMH)
• Treatments: Clonazepam; Serotonin Uptake Inhibitors; Sertraline

Criteria

Inclusion Criteria:

• Diagnosis of panic disorder

Exclusion Criteria:

• History of bipolar disorder, schizophrenia, psychosis, or delusional disorders

• Post-traumatic stress disorder diagnosis within 6 months prior to study entry

• Current use of psychotropic medications

• Current use of cognitive behavioral therapy